US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

32.30

+0.08160.25%

Post-market: 32.390.0900+0.28%16:10 EDT

Volume:7K

Turnover:224.07K

Market Cap:23.41M

PE:- -

High:32.55

Open:32.41

Low:32.30

Close:32.21

52wk High:36.27

52wk Low:29.01

Shares:725.00K

Float Shares:725.00K

Volume Ratio:4.30

T/O Rate:0.95%

Dividend:0.76

Dividend Rate:2.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

4D Molecular Therapeutics Enrolls First Patients in Phase 3 4sight Trial of 4D-150 for Diabetic Macular Edema

Fobi AI Shifts Focus to Flywheel Product Stack, Targets Legacy Business Transition by End-2026

Harvard Ave Acquisition Agrees to Merge with Pipeline Services Provider OAG International

ALX Oncology Says Phase 2 ASPEN-06 Study Shows 40.3% Response Rate for Evorpacept Combo in HER2-Positive Gastric Cancer

Allarity Therapeutics Expands In-House Lab to Add Proteomics, Cell Line Research

Lantheus Doses First Patient in Sparrow Phase 2/3 Prostate Cancer Imaging Trial for LNTH-2401

Humacyte Adds Scott Coward to Board, Names Him to Audit Committee

ReconAfrica Resumes Work at Namibia KW1X as Horizontal Drilling Nears

NeOnc Technologies Schedules FDA End-of-Phase 1 Meeting for Brain Cancer Drug Neo212

GuideAI Health Renews Exclusive Imaging Data Collaboration with vRad

NetSol GAAP Operating Income More than Doubles to $6.9 Million in FY26; Revenue Rises 12.5% to $74.4 Million

Newtek Bank Expands Account Connectivity to Sage, Xero, FreshBooks, Restaurant365

OSB Group CEO Enrique Alvarez Labiano Sells Shares Worth GBP 1.08 Million

Draganfly Prices Registered Direct Share Sale at Us$5.35 for US$10 Million

Fairfax Launches NCIB to Buy Back up to 2,025,315 Shares, 950,000 Series K Preferred Shares

Immuneering Presents AACR Data Linking Atebimetinib Plus mGnP to Longer Survival in Pancreatic Cancer Study

CervoMed Plans Neflamapimod 100 Mg Twice-Daily Regimen for Future Clinical Trials

Valley National Bancorp to Buy Bluevine for USD 340 Million

Scynexis Wins BARDA Contract Worth up to $214 Million for SCY-247 Development

Base Carbon Says Verra Tags 639,609 Rwanda Cookstove Credits as Corsia-Eligible

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BCDF/news?page=64"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","market":"US","secType":"STK","nameCN":"Horizon Kinetics Blockchain Development ETF","latestPrice":32.295,"timestamp":1791316800000,"preClose":32.2134,"halted":0,"volume":6908,"hourTrading":{"tag":"盘后","latestPrice":32.385,"preClose":32.295,"latestTime":"16:10 EDT","volume":6,"amount":193.77,"timestamp":1791317404345,"change":0.09,"changeRate":0.002787,"amplitude":0},"delay":0,"changeRate":0.0025331073404236022,"floatShares":725000,"shares":725000,"eps":0,"marketStatus":"Not Yet Opened","change":0.0816,"latestTime":"10-06 16:00:00 EDT","open":32.4094,"high":32.55,"low":32.295,"amount":224074,"amplitude":0.007916,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791360000000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":32.2134,"sharesOutstanding":675000,"nav":32.15,"aum":23308750,"dividendRate":0.023638,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.385,"preClose":32.295,"latestTime":"16:10 EDT","volume":6,"amount":193.77,"timestamp":1791317404345,"change":0.09,"changeRate":0.002787,"amplitude":0},"volumeRatio":4.29602},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDF\",,,,,undefined,":{"symbol":"BCDF","floatShares":725000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.29602,"shares":725000,"dividePrice":0.7634,"high":32.55,"amplitude":0.007916,"preClose":32.2134,"low":32.295,"week52Low":29.01,"pbRate":"--","week52High":36.27,"institutionHeld":0,"latestPrice":32.295,"eps":0,"divideRate":0.023638,"volume":6908,"delay":0,"ttmEps":0,"open":32.4094,"prevYearClose":30.2172,"prevWeekClose":31.9937,"prevMonthClose":32.0003,"prevQuarterClose":32.0003,"fiveDayClose":32.0442,"twentyDayClose":33.86,"sixtyDayClose":31.1389},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDF\",params:#limit:5,,,undefined,":[{"date":"2024-12-24","symbol":"BCDF","amount":0.45302,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"Horizon Kinetics Blockchain Development ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"BCDF","amount":0.169967,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"},{"market":"US","date":"2022-12-28","symbol":"BCDF","amount":0.05244,"defaultRemindTime":1672237800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2022-09-28","symbol":"BCDF","amount":0.0219,"defaultRemindTime":1664371800000,"name":"Horizon Kinetics Blockchain Development ETF","recordDate":"2022-09-30","payableDate":"2022-09-29","currency":"USD","type":"dividend","dateTimestamp":1664337600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDF\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-28","recordDate":"2022-09-29","paymentDate":"2022-09-30","value":0.0219,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.05244,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.169967,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.45302,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCDF\",pageSize:20,pageCount:64,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670232640","title":"4D Molecular Therapeutics Enrolls First Patients in Phase 3 4sight Trial of 4D-150 for Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232640","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232640?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:06","pubTimestamp":1790597217,"startTime":"0","endTime":"0","summary":"4D Molecular Therapeutics enrolls first patients in Phase 3 4SIGHT trial of 4D-150 for diabetic macular edema4D Molecular Therapeutics enrolled the first patients in 4SIGHT, a global Phase 3 trial of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLcfzTFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4139","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","FDMT","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232613","title":"Fobi AI Shifts Focus to Flywheel Product Stack, Targets Legacy Business Transition by End-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232613","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232613?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:05","pubTimestamp":1790597113,"startTime":"0","endTime":"0","summary":"Fobi AI shifts focus to Flywheel product stack, targets legacy business transition by end-2026Fobi AI outlined a reorganization to pivot from multiple legacy units to a single product ecosystem built ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL3H0fZq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","SG9999014021.USD","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","BK4585","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670023261","title":"Harvard Ave Acquisition Agrees to Merge with Pipeline Services Provider OAG International","url":"https://stock-news.laohu8.com/highlight/detail?id=2670023261","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670023261?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:05","pubTimestamp":1790597108,"startTime":"0","endTime":"0","summary":"Harvard Ave Acquisition agrees to merge with pipeline services provider OAG InternationalHarvard Ave Acquisition entered a definitive business combination agreement with OAG International, a pipeline ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4qh5GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","HAVA","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670578232","title":"ALX Oncology Says Phase 2 ASPEN-06 Study Shows 40.3% Response Rate for Evorpacept Combo in HER2-Positive Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670578232","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670578232?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:04","pubTimestamp":1790597098,"startTime":"0","endTime":"0","summary":"ALX Oncology says Phase 2 ASPEN-06 study shows 40.3% response rate for evorpacept combo in HER2-positive gastric cancerALX Oncology reported already-published Phase 2 ASPEN-06 data in Nature Medicine ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLhCXwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","IE00BQXX3F31.USD","LU0314104364.USD","IE00BN0W2V16.EUR","BK4585","BK4139","IE00BQXX3D17.EUR","ALXO","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","IE00BQXX3C00.GBP","SG9999014039.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232526","title":"Allarity Therapeutics Expands In-House Lab to Add Proteomics, Cell Line Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232526","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232526?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:04","pubTimestamp":1790597090,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics expands in-house lab to add proteomics, cell line researchAllarity Therapeutics expanded its in-house medical laboratory to add proteomics and cell line research capabilities.Bui","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8hDC8g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","BK4112","BK4585","ALLR","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232520","title":"Lantheus Doses First Patient in Sparrow Phase 2/3 Prostate Cancer Imaging Trial for LNTH-2401","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232520","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232520?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:04","pubTimestamp":1790597071,"startTime":"0","endTime":"0","summary":"Lantheus doses first patient in SPARROW Phase 2/3 prostate cancer imaging trial for LNTH-2401Lantheus dosed the first patient in SPARROW, a Phase 2/3 registrational study of LNTH-2401 PET imaging in p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL6HWrQ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNTH","BCDF","BK4198","IE00B64PRP62.GBP","BK4112","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","NDAQ","BK4585","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423256","title":"Humacyte Adds Scott Coward to Board, Names Him to Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423256","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:03","pubTimestamp":1790596983,"startTime":"0","endTime":"0","summary":"Humacyte adds Scott Coward to board, names him to audit committeeHumacyte added Scott Coward and Paul Kuznik to its board as it expands the Symvess launch and prepares an ATEV dialysis-access launch.C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL2fwfyJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237957811.SGD","SG9999002232.USD","SG9999014005.SGD","BK4585","LU0122379950.USD","ABT","BK4566","SGXZ41872573.SGD","LU2237957902.USD","IE00B3QW5Z07.USD","BK4082","IE0002141913.USD","LU1670628061.USD","TMED","SG9999004303.SGD","IE00BQXX3F31.USD","LU0170899867.USD","IHI","LU2095319765.USD","LU0070302665.USD","SG9999002224.SGD","IE00B2B36J28.USD","NDAQ","PJP","BK4568","HUMA","IE00BQXX3C00.GBP","BCDF","LU2210150020.SGD","BK4112","LU0211331839.USD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU2133065610.SGD","LU0314104364.USD","LU0266013472.USD","LU1983299246.USD","LU1989763690.USD","LU0320765489.SGD","LU0208291251.USD","LU1721429741.USD","LU1057294990.SGD","IE0009355771.USD","BK4588","SG9999014021.USD","LU2468319806.SGD","IE00BN0W2V16.EUR","LU0058720904.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670323230","title":"ReconAfrica Resumes Work at Namibia KW1X as Horizontal Drilling Nears","url":"https://stock-news.laohu8.com/highlight/detail?id=2670323230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670323230?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:02","pubTimestamp":1790596973,"startTime":"0","endTime":"0","summary":"ReconAfrica resumes work at Namibia KW1X as horizontal drilling nearsReconnaissance Energy Africa restarted work at its KW1X discovery well in Namibia ahead of a planned horizontal flow test.Flow-test","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8F0LN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","SG9999014039.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4112","IE00B3QW5Z07.USD","BCDF","IE00B64PRP62.GBP","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","BK4585","LU0314104364.USD","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232305","title":"NeOnc Technologies Schedules FDA End-of-Phase 1 Meeting for Brain Cancer Drug Neo212","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232305","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232305?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:02","pubTimestamp":1790596923,"startTime":"0","endTime":"0","summary":"NeOnc Technologies schedules FDA end-of-Phase 1 meeting for brain cancer drug NEO212NeOnc Technologies scheduled an in-person FDA End-of-Phase 1 meeting for NEO212 on Nov. 17, 2026.Phase 1 results wer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8Gwndh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","BK4007","NTHI","IE00BQXX3C00.GBP","BCDF","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232381","title":"GuideAI Health Renews Exclusive Imaging Data Collaboration with vRad","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232381","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232381?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:01","pubTimestamp":1790596915,"startTime":"0","endTime":"0","summary":"GuideAI Health renews exclusive imaging data collaboration with vRadGuideAI Health renewed an exclusive data agreement with vRad to develop AI models for vascular disease detection.Renewal extends exc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL5lFkch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014005.SGD","BK4588","LU2095319765.USD","IE00BQXX3F31.USD","BCDF","BK4585","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670023287","title":"NetSol GAAP Operating Income More than Doubles to $6.9 Million in FY26; Revenue Rises 12.5% to $74.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2670023287","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670023287?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:01","pubTimestamp":1790596908,"startTime":"0","endTime":"0","summary":"NetSol GAAP operating income more than doubles to $6.9 million in FY26; revenue rises 12.5% to $74.4 millionNetSol posted Q4 revenue of $20.7 million, up 12.5% year over year, while operating income c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8s55v0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","IE00BQXX3D17.EUR","IE00BKPKM429.USD","BK4023","SG9999014039.USD","IE00BGHQF748.EUR","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","NTWK","IE00BQXX3C00.GBP","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","IE00BQXX3F31.USD","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670323832","title":"Newtek Bank Expands Account Connectivity to Sage, Xero, FreshBooks, Restaurant365","url":"https://stock-news.laohu8.com/highlight/detail?id=2670323832","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670323832?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:01","pubTimestamp":1790596868,"startTime":"0","endTime":"0","summary":"Newtek Bank expands account connectivity to Sage, Xero, FreshBooks, Restaurant365Newtek Bank expanded connectivity between its accounts and business software, adding integrations with Sage, Xero, Fres","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8zHbg7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BKPKM429.USD","BK4184","LU2095319765.USD","IE00BQXX3C00.GBP","BK4135","NEWT","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","BK4112","BCDF","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234164","title":"OSB Group CEO Enrique Alvarez Labiano Sells Shares Worth GBP 1.08 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234164","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234164?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:46","pubTimestamp":1790595961,"startTime":"0","endTime":"0","summary":"OSB Group CEO Enrique Alvarez Labiano sells shares worth GBP 1.08 millionOSB Group CEO Enrique Alvarez Labiano vested 450,532 ordinary shares under a recruitment award.He sold 212,494 shares at GBP 5.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL3gRVKh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"OSB Group CEO Enrique Alvarez Labiano Sells Shares Worth GBP 1.08 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","BK4588","NDAQ","IE00BQXX3F31.USD","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014021.USD","IE00BGHQF748.EUR","BCDF","LU2095319765.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234150","title":"Draganfly Prices Registered Direct Share Sale at Us$5.35 for US$10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234150","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234150?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:45","pubTimestamp":1790595937,"startTime":"0","endTime":"0","summary":"Draganfly prices registered direct share sale at US$5.35 for US$10 millionDraganfly priced a US$10 million registered direct offering of 1,869,159 common shares at US$ 5.35.Unusual Machines invested U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL3yFpxZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4112","IE00BN0W2T93.GBP","DRNZ","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","UMAL","SG9999014039.USD","BK4603","SG9999014021.USD","LU2210150020.SGD","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU0314104364.USD","BK4157","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ","IE00BQXX3F31.USD","BK4585","UMAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234168","title":"Fairfax Launches NCIB to Buy Back up to 2,025,315 Shares, 950,000 Series K Preferred Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234168","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234168?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:45","pubTimestamp":1790595935,"startTime":"0","endTime":"0","summary":"Fairfax launches NCIB to buy back up to 2,025,315 shares, 950,000 Series K preferred sharesFairfax Financial plans a normal course issuer bid to repurchase up to 2,025,315 subordinate voting shares fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL5d5lJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","BK4588","IE00BQXX3C00.GBP","LU2210150020.SGD","LU0314104364.USD","BCDF","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4585","BK4112","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670823484","title":"Immuneering Presents AACR Data Linking Atebimetinib Plus mGnP to Longer Survival in Pancreatic Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670823484","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670823484?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:32","pubTimestamp":1790595141,"startTime":"0","endTime":"0","summary":"Immuneering presents AACR data linking atebimetinib plus mGnP to longer survival in pancreatic cancer studyImmuneering presented new exploratory clinical data at the 2026 AACR Conference on Pancreatic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8W47Q4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","BK4539","BK4112","IE00BN0W2V16.EUR","NDAQ","BK4588","BK4563","SG9999014005.SGD","IE00BQXX3D17.EUR","IMRX","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4139","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234810","title":"CervoMed Plans Neflamapimod 100 Mg Twice-Daily Regimen for Future Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234810","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234810?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:32","pubTimestamp":1790595135,"startTime":"0","endTime":"0","summary":"CervoMed plans neflamapimod 100 mg twice-daily regimen for future clinical trialsCervoMed disclosed Phase 1 study results for a new neflamapimod 50 mg tablet, positioning it for twice-daily dosing.The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLbTjnxJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00B64PRP62.GBP","CRVO","BK4112","IE00BQXX3D17.EUR","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014005.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","NDAQ","BK4585","LU2095319765.USD","BK4588","BK4139","IE00BN0W2W23.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670814234","title":"Valley National Bancorp to Buy Bluevine for USD 340 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2670814234","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670814234?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:32","pubTimestamp":1790595121,"startTime":"0","endTime":"0","summary":"Valley National Bancorp to buy Bluevine for USD 340 millionValley National Bancorp agreed to buy digital small-business banking platform Bluevine for about $340 million, paid 75% in cash, 25% stock.De","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLbfYKVn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014021.USD","IE00BQXX3F31.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","VLY","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014013.SGD","BK4211","BK4588","LU0314104364.USD","BCDF","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234854","title":"Scynexis Wins BARDA Contract Worth up to $214 Million for SCY-247 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234854","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234854?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:31","pubTimestamp":1790595104,"startTime":"0","endTime":"0","summary":"SCYNEXIS wins BARDA contract worth up to $214 million for SCY-247 developmentSCYNEXIS won a BARDA contract worth up to USD 214 million to fund development of its SCY-247 antifungal through potential N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL9rMx4H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4585","IE00B64PRP62.GBP","SCYX","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","BK4588","LU2210150020.SGD","BK4007","BK4112","IE00BQXX3C00.GBP","NDAQ","LU0314104364.USD","SG9999014013.SGD","IE00BQXX3F31.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670923485","title":"Base Carbon Says Verra Tags 639,609 Rwanda Cookstove Credits as Corsia-Eligible","url":"https://stock-news.laohu8.com/highlight/detail?id=2670923485","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670923485?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:31","pubTimestamp":1790595068,"startTime":"0","endTime":"0","summary":"Base Carbon says Verra tags 639,609 Rwanda cookstove credits as CORSIA-eligibleBase Carbon reported Verra tagged 639,609 previously issued Rwanda cookstoves carbon credits as CORSIA-eligible for 2024-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL9mPdzt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","LU0314104364.USD","IE00BQXX3F31.USD","IE00BKPKM429.USD","BK4112","BK4588","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":87,"pageCount":64,"totalSize":1722,"code":"91000000","status":"200"}]}}